These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26715152)

  • 21. Botulinum toxin in urinary incontinence.
    Patterson JM; Chapple CR
    Curr Opin Urol; 2006 Jul; 16(4):255-60. PubMed ID: 16770124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin injection for chronic pelvic pain: A systematic review.
    Luo FY; Nasr-Esfahani M; Jarrell J; Robert M
    Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1595-1602. PubMed ID: 32597494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia.
    Spiegel LL; Ostrem JL; Bledsoe IO
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32429600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of botulinum toxin in management of pain: an evidence-based review.
    Qerama E; Fuglsang-Frederiksen A; Jensen TS
    Curr Opin Anaesthesiol; 2010 Oct; 23(5):602-10. PubMed ID: 20585245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
    Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin treatment of temporomandibular joint pain in patients with bruxism: A prospective and randomized clinical study.
    Kaya DI; Ataoglu H
    Niger J Clin Pract; 2021 Mar; 24(3):412-417. PubMed ID: 33723117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and pharmacodynamics of a novel recombinant botulinum toxin E (rBoNT-E): Results of a phase 1 study in healthy male subjects compared with abobotulinumtoxinA (Dysport®).
    Pons L; Vilain C; Volteau M; Picaut P
    J Neurol Sci; 2019 Dec; 407():116516. PubMed ID: 31655410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumatic dilation and botulinum toxin: when and why?
    Bozzi R; Di Martino V; Inzirillo A; D'Avenia E; Inzirillo M; Cattaneo F; Cattaneo D
    Ann Ital Chir; 2013; 84(5):501-4. PubMed ID: 24141252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction to the Toxins Special Issue on Botulinum Neurotoxins in the Nervous System: Future Challenges for Novel Indications.
    Luvisetto S
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957443
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of botulinum toxin in Parkinson's disease.
    Jocson A; Lew M
    Parkinsonism Relat Disord; 2019 Feb; 59():57-64. PubMed ID: 30579818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum neurotoxin (BoNT) treatment in functional movement disorders: long-term follow-up.
    Dreissen YE; Lambert F; Dijk JM; Koelman JH; Tijssen MA
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1120-1121. PubMed ID: 32661081
    [No Abstract]   [Full Text] [Related]  

  • 33. Botulinum toxin A in the treatment of myofascial pain and dysfunction: the case against its use.
    Laskin DM
    J Oral Maxillofac Surg; 2012 May; 70(5):1240-2. PubMed ID: 22538023
    [No Abstract]   [Full Text] [Related]  

  • 34. Botulinum toxin injection into the lacrimal gland for treatment of proximal nasolacrimal duct obstructions in children.
    Eustis HS; Babiuch A
    J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e75-7. PubMed ID: 25427340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Botulinum Toxin as a Therapeutic Agent: Molecular Structure and Mechanism of Action in Motor and Sensory Systems.
    Kumar R; Dhaliwal HP; Kukreja RV; Singh BR
    Semin Neurol; 2016 Feb; 36(1):10-9. PubMed ID: 26866491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.
    Mitchell SD; Sidiropoulos C
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease-oriented approach to botulinum toxin use.
    Jankovic J
    Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Botulinum Toxin on Flap Viability of the Posterior Thigh Perforator Flap in Rats.
    Erdem M; Tiftikcioglu Y; Tatar BE; Kılıc KD; Uyanıkgil Y; Gürler T
    J Surg Res; 2021 May; 261():85-94. PubMed ID: 33422903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study.
    Al-Wayli H
    J Clin Exp Dent; 2017 Jan; 9(1):e112-e117. PubMed ID: 28149474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force.
    Dressler D; Bhidayasiri R; Bohlega S; Chahidi A; Chung TM; Ebke M; Jacinto LJ; Kaji R; Koçer S; Kanovsky P; Micheli F; Orlova O; Paus S; Pirtosek Z; Relja M; Rosales RL; Sagástegui-Rodríguez JA; Schoenle PW; Shahidi GA; Timerbaeva S; Walter U; Saberi FA
    J Neurol; 2017 Jan; 264(1):112-120. PubMed ID: 27787630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.